| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.92T | 1.88T | 1.89T | 1.68T | 1.43T |
| Gross Profit | 297.04B | 315.62B | 317.75B | 285.11B | 235.83B |
| EBITDA | 146.87B | 135.27B | 143.88B | 121.14B | 107.62B |
| Net Income | 11.97B | 13.71B | 40.26B | 34.28B | 20.68B |
Balance Sheet | |||||
| Total Assets | 1.58T | 1.57T | 1.63T | 1.44T | 1.39T |
| Cash, Cash Equivalents and Short-Term Investments | 137.55B | 119.06B | 167.02B | 123.85B | 124.25B |
| Total Debt | 217.12B | 248.36B | 250.84B | 263.34B | 268.50B |
| Total Liabilities | 752.46B | 787.92B | 805.74B | 740.62B | 726.04B |
| Stockholders Equity | 790.21B | 745.04B | 788.98B | 667.23B | 624.01B |
Cash Flow | |||||
| Free Cash Flow | 19.00B | -8.06B | 95.72B | 22.50B | 24.36B |
| Operating Cash Flow | 108.50B | 80.24B | 154.46B | 78.28B | 67.04B |
| Investing Cash Flow | -52.70B | -75.94B | -71.35B | -52.11B | -25.27B |
| Financing Cash Flow | -46.98B | -52.08B | -47.22B | -28.71B | -43.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥531.09B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
74 Outperform | ¥556.57B | 11.33 | ― | 2.60% | 1.02% | -2.46% | |
68 Neutral | ¥5.22T | 11.95 | 6.98% | 2.98% | 5.28% | 12.66% | |
68 Neutral | ¥616.18B | 28.26 | ― | 3.52% | 7.58% | 162.60% | |
66 Neutral | ¥594.33B | 43.48 | 3.35% | 3.18% | 2.15% | -6.81% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥1.79T | 9.32 | 8.34% | 2.03% | 4.53% | 65.12% |